These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 6099463)

  • 21. Persistence of protective immunity after inoculation with live varicella vaccine (strain Oka).
    Asano Y; Nagai T; Miyata T; Yazaki T; Ito S; Yamanishi K; Takahashi M
    Biken J; 1984 Sep; 27(2-3):123-8. PubMed ID: 6100049
    [No Abstract]   [Full Text] [Related]  

  • 22. Chickenpox vaccination of healthy children: immunological and clinical responses and protective effect in 1978-1982.
    Horiuchi K
    Biken J; 1984 Sep; 27(2-3):37-8. PubMed ID: 6100055
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinical trial of the Oka strain of live attenuated varicella vaccine on healthy children.
    Ozaki T; Matsui T; Ichikawa T; Asano Y; Yamanishi K; Takahashi M
    Biken J; 1984 Sep; 27(2-3):39-42. PubMed ID: 6100056
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [A new preparation of specific anti-varicella-zoster immunoglobulin. Clinical evaluation in immunodepressed subjects].
    Miceli Sopo S; Pesaresi MA; Stabile A
    Minerva Pediatr; 1987 Apr; 39(8):317-9. PubMed ID: 3614159
    [No Abstract]   [Full Text] [Related]  

  • 25. Experience and reason: twenty-year follow-up of protective immunity of the Oka strain live varicella vaccine.
    Asano Y; Suga S; Yoshikawa T; Kobayashi I; Yazaki T; Shibata M; Tsuzuki K; Ito S
    Pediatrics; 1994 Oct; 94(4 Pt 1):524-6. PubMed ID: 7936864
    [No Abstract]   [Full Text] [Related]  

  • 26. Spread of varicella in hospitalized children having no direct contact with an indicator zoster case and its prevention by a live vaccine.
    Asano Y; Iwayama S; Miyata T; Yazaki T; Ozaki T; Tsuzuki K; Ito S; Takahashi M
    Biken J; 1980 Sep; 23(3):157-61. PubMed ID: 6257228
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Varicella zoster immunoglobulin. Prophylactic use in risk patients].
    Geursen RG
    ZFA (Stuttgart); 1983 Mar; 59(7):342-7. PubMed ID: 6303013
    [No Abstract]   [Full Text] [Related]  

  • 28. Use and limitations of varicella-zoster virus-specific serological testing to evaluate breakthrough disease in vaccinees and to screen for susceptibility to varicella.
    Breuer J; Schmid DS; Gershon AA
    J Infect Dis; 2008 Mar; 197 Suppl 2():S147-51. PubMed ID: 18419389
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Live attenuated varicella vaccine: the KMcC strain in healthy children.
    Arbeter AM; Starr SE; Weibel RE; Neff BJ; Plotkin SA
    Pediatrics; 1983 Mar; 71(3):307-12. PubMed ID: 6298698
    [TBL] [Abstract][Full Text] [Related]  

  • 30. What's new in chickenpox (varicella-zoster) infection?
    Gershon AA
    West J Med; 1993 Feb; 158(2):180. PubMed ID: 8382001
    [No Abstract]   [Full Text] [Related]  

  • 31. Effect and follow-up study on varicella vaccine.
    Katsushima N; Yazaki N; Sakamoto M
    Biken J; 1984 Sep; 27(2-3):51-8. PubMed ID: 6100058
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Editorial: Varicella-zoster infections: zoster immune globulin.
    Hussey HH
    JAMA; 1974 May; 228(7):876. PubMed ID: 4362716
    [No Abstract]   [Full Text] [Related]  

  • 33. Varicella zoster vaccines.
    Creed R; Satyaprakash A; Ravanfar P
    Dermatol Ther; 2009; 22(2):143-9. PubMed ID: 19335725
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Five-year follow-up study of recipients of live varicella vaccine using enhanced neutralization and fluorescent antibody membrane antigen assays.
    Asano Y; Albrecht P; Vujcic LK; Quinnan GV; Kawakami K; Takahashi M
    Pediatrics; 1983 Sep; 72(3):291-4. PubMed ID: 6310478
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Evaluation of varicella vaccine in childhood leukemia. Observation over 6 years.
    Oka T; Iseki K; Oka R; Sakuma S; Yoshioka H; Takahashi M
    Biken J; 1984 Sep; 27(2-3):103-9. PubMed ID: 6100045
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Acyclovir prophylaxis of varicella after household exposure.
    Huang YC; Lin TY; Chiu CH
    Pediatr Infect Dis J; 1995 Feb; 14(2):152-4. PubMed ID: 7746701
    [No Abstract]   [Full Text] [Related]  

  • 37. Humoral and cell-mediated immune responses in children and adults after 1 and 2 doses of varicella vaccine.
    Watson B
    J Infect Dis; 2008 Mar; 197 Suppl 2():S143-6. PubMed ID: 18419388
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Varicella vaccination: where do we go from here?
    Brunell PA
    Hosp Pract; 1980 Sep; 15(9):91-3, 97, 100-1 passim. PubMed ID: 6250972
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Trial of a varicella vaccine in 100 high-risk children].
    Vialatte J; Broyer M; Griscelli C; Gaiffe M; Badillet M; Georges AM
    Dev Biol Stand; 1982; 52():385-90. PubMed ID: 6299848
    [No Abstract]   [Full Text] [Related]  

  • 40. Loss of varicella zoster virus antibodies despite detectable cell mediated immunity after vaccination.
    Ludwig B; Kraus FB; Allwinn R; Keim S; Doerr HW; Buxbaum S
    Infection; 2006 Aug; 34(4):222-6. PubMed ID: 16896582
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.